ARTICLE
|
doi:10.20944/preprints202308.1899.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
SARS-CoV-2; BNT162b2 vaccine; cancer patients; anti-neoplastic treatment; chemotherapy; antibodies; immunogenicity.
Online: 29 August 2023 (03:49:55 CEST)